SV2A and early-onset autosomal dominant Alzheimer disease: For example, in Alzheimer’s disease, which is characterised by synapse loss during the early stages, it would be informative to determine whether and how SV2A-positive synapse types and subtypes are affected at the different stages of disease progression.